PLATANIA, CHIARA BIANCA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 3.475
EU - Europa 2.027
AS - Asia 1.882
AF - Africa 346
SA - Sud America 298
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 3
Totale 8.038
Nazione #
US - Stati Uniti d'America 3.365
SG - Singapore 891
IT - Italia 689
RU - Federazione Russa 644
CN - Cina 506
BR - Brasile 244
IE - Irlanda 202
CI - Costa d'Avorio 184
VN - Vietnam 161
UA - Ucraina 90
KR - Corea 88
DE - Germania 81
FR - Francia 80
SN - Senegal 70
CA - Canada 65
GB - Regno Unito 60
IN - India 46
NG - Nigeria 41
SE - Svezia 32
BD - Bangladesh 29
HK - Hong Kong 29
MX - Messico 29
JP - Giappone 28
PL - Polonia 28
FI - Finlandia 26
NL - Olanda 25
ZA - Sudafrica 19
AR - Argentina 18
ES - Italia 16
TR - Turchia 16
IQ - Iraq 15
PK - Pakistan 12
EC - Ecuador 9
ID - Indonesia 9
KE - Kenya 9
AE - Emirati Arabi Uniti 8
BE - Belgio 8
BJ - Benin 8
LT - Lituania 8
CH - Svizzera 6
CO - Colombia 6
VE - Venezuela 6
AT - Austria 5
CL - Cile 5
CZ - Repubblica Ceca 5
GR - Grecia 5
MA - Marocco 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
EU - Europa 4
HR - Croazia 4
NP - Nepal 4
PY - Paraguay 4
TN - Tunisia 4
AU - Australia 3
AZ - Azerbaigian 3
JO - Giordania 3
LB - Libano 3
NI - Nicaragua 3
PH - Filippine 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
BO - Bolivia 2
CY - Cipro 2
DK - Danimarca 2
EG - Egitto 2
GD - Grenada 2
GT - Guatemala 2
KG - Kirghizistan 2
MY - Malesia 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
OM - Oman 1
QA - Qatar 1
RO - Romania 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 8.035
Città #
Singapore 560
Santa Clara 464
Dallas 434
Chandler 321
San Jose 282
Moscow 275
Ashburn 207
Dublin 202
Abidjan 184
Catania 184
Chicago 168
Hefei 128
Jacksonville 96
Houston 93
Seoul 85
Beijing 83
Boardman 83
Dakar 70
Los Angeles 70
Lauterbourg 61
Ho Chi Minh City 53
New York 51
Cambridge 48
Lawrence 47
Andover 43
Council Bluffs 39
Hanoi 39
Civitanova Marche 35
Orem 31
Rome 30
São Paulo 30
Toronto 27
Wilmington 27
Buffalo 25
Hong Kong 25
Des Moines 24
Nanjing 23
Palermo 23
Tokyo 23
Abuja 22
Bremen 21
Seattle 20
Warsaw 19
The Dalles 18
Phoenix 17
Aci Catena 16
Columbus 16
Falls Church 16
Lagos 16
Messina 16
Montreal 16
Atlanta 15
Rio de Janeiro 14
Brooklyn 13
Johannesburg 13
Milan 13
Munich 13
Lappeenranta 12
Stockholm 12
Redwood City 11
Boydton 10
Changsha 10
Denver 10
Dong Ket 10
Hebei 10
Manchester 10
Mexico City 10
Mumbai 10
Ottawa 10
Saint Petersburg 10
Shenyang 10
Belo Horizonte 9
City of London 9
Naples 9
San Mateo 9
Amsterdam 8
Cotonou 8
Grafing 8
London 8
Nairobi 8
Redmond 8
Redondo Beach 8
Ankara 7
Chennai 7
Jiaxing 7
Nanchang 7
San Francisco 7
San Gregorio di Catania 7
Washington 7
Baghdad 6
Brasília 6
Cagliari 6
Dearborn 6
Frankfurt am Main 6
Guangzhou 6
Pozzallo 6
Rosolini 6
Shanghai 6
Turin 6
Boston 5
Totale 5.338
Nome #
Current drug treatments targeting dopamine D3 receptor 243
Antioxidant and osmoprotecting activity of taurine in dry eye models 195
Caffeine Protects Against Retinal Inflammation 184
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 165
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 165
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 164
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 160
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 158
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 157
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy 156
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 155
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 151
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice 151
Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle-associated protein: Implications for diabetic retinopathy 149
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 140
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 140
Controversies in Glaucoma: Current Medical Treatment and Drug Development 139
Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study 137
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 137
Drug delivery of synthetic antisense “Bioconjugates” for anticancer therapy DNA. 135
Dihydrotanshinone, a natural diterpenoid, preserves blood-retinal barrier integrity via p2x7 receptor 132
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 131
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 131
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 131
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 129
New Brilliant Blue G Derivative as Pharmacological Tool in Retinal Surgery 127
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 127
Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye 127
Retinal protection and distribution of curcumin in vitro and in vivo 126
Novel therapeutics in glaucoma management 125
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 125
Ocular pharmacological profile of hydrocortisone in dry eye disease 125
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa 121
P2X7 receptor antagonism: implications in diabetic retinopathy 119
Drug Delivery of Synthetic Antisense-DNA “bioconjugates” for Anticancer Therapy 119
Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets? 118
Do extracellular RNAs provide insight into uveal melanoma biology? 117
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 115
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 115
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 115
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 114
Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration 114
Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells 113
Integrating network pharmacology: The next-generation approach in ocular drug discovery 111
Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR) 106
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 100
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 100
Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease 99
In-Silico Characterization of von Willebrand Factor Bound to FVIII 98
Small molecules to treat angiogenesis and inflammation in an in-vitro model of diabetic retinopathy 97
DRUG DELIVERY OF SYNTHETIC ANTISENSE-DNA "BIOCONJUGATES" FOR ANTICANCER THERAPY 96
Characterization of protein-protein interfaces through a protein contact network approach 93
Stabilization of HIF-1α in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth Factors 93
Resolvin D1 Modulates the Intracellular VEGF-Related miRNAs of Retinal Photoreceptors Challenged With High Glucose 92
Ocular pharmacological and biochemical profiles of 6-thioguanine: a drug repurposing study 89
MicroRNA target prediction in glaucoma 89
The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach 85
Ocular allergy 82
Novel heme oxygenase-1 (Ho-1) inducers based on dimethyl fumarate structure 82
Molecular basis of alcohol intake: role of D3 dopaminergic receptor 79
Implications of dopamine D3 receptor for glaucoma: in-silico and in-vivo studies 78
α1D Adrenergic Receptor Antagonism Protects Against High Glucose-Induced Mitochondrial Dysfunction and Blood Retinal Barrier Breakdown in ARPE-19 Cells 75
The P2X7 receptor as a new pharmacological target for retinal diseases 73
Ocular Allergies 66
Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs 66
Erratum: Homology modeling of dopamine D2 and D3 receptors: Molecular dynamics refinement and docking evaluation (PLoS ONE (2013) 8:1 DOI: 10.1371/annotation/bd61cc74-2a2c-4433-a78d-84fa2310e919) 64
Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach. 64
Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease 42
Retinal alterations resemble brain pathology in a rat model of Parkinson’s disease induced by intranigral infusion of α-synuclein oligomers 21
Selective phosphoinositide 3-kinase inhibitors and implication in diabetic retinopathy as pharmacological tools 16
Safety and effectiveness of vital dyes for intraocular surgery 16
Selective phosphoinositide 3-kinase inhibitors and implication in diabetic retinopathy as pharmacological tools 6
Totale 8.175
Categoria #
all - tutte 25.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.178


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 0 0 0 0 0 0 0 0 0 20
2021/2022385 31 45 10 6 50 18 64 21 32 6 19 83
2022/2023927 61 66 17 109 121 120 16 170 173 16 31 27
2023/2024403 32 43 18 21 31 115 7 30 1 3 57 45
2024/20251.799 42 258 80 128 378 244 104 57 129 109 155 115
2025/20263.967 251 196 614 252 558 794 416 85 208 274 216 103
Totale 8.175